Injectable Therapy May Avert Rotator Cuff Injuries
By HospiMedica International staff writers Posted on 25 Dec 2013 |
An injectable compound under development could inhibit the breakdown of the supraspinatus tendon, a rotator cuff tendon that is commonly torn in sports.
Researchers at Georgia Tech (Atlanta, USA) and Emory University (Atlanta, GA, USA) are conducting a study to develop improved regenerative medicine strategies to aid repair of tendinopathic tissues. Since one of the hallmarks of tendinopathy is disruption of extracellular matrix (ECM), and particularly collagen, the researcher set out to test which classes of ECM proteases are involved in the tissue degeneration, and develop treatments to deliver inhibitory agents for these enzymes to reduce pathology progression and improve healing.
The central hypothesis of the researchers is that long-term regulation of protease activity in tendinopathy using a protease inhibitor will result in greater tendon tissue structure and mechanical properties. To do so, proteases and inhibitors related to ECM degradation will be tested in vivo in a rat supraspinatus tendon overuse model. The researchers hope to develop a controlled, injectable carrier to achieve local, sustained release of protease inhibitors. The researchers will also study the histology and mechanics of the tendons after healing.
“Normally people focus on treating tendon injuries after the tear has occurred, but we’re focusing on a much earlier stage in the disease,” said lead researcher associate professor Johnna Temenoff, PhD, of the department of Biomedical Engineering. “This is the first time that an injectable therapy specifically designed to interact with tissue at an early disease state has been attempted for this particular tendon injury.”
“We’re studying enzymes that are known to chew up the collagen, and we’re looking at then delivering inhibitors to those enzymes in a local injection in the tendon to try to stop the degradation,” added Dr. Temenoff. “We’re studying the disease in the shoulder, but it’s the same disease that causes tennis elbow, Achilles injuries, and jumper’s knee. It’s the same process, just in different tendons in the body.”
Tendinopathy is a common disorder resulting from repetitive motion in the workplace or during athletic activity that can cause severe pain and long-term disability due to tendon damage in the rotator cuff, a collation of four tendons made of collagen.
Related Links:
Georgia Tech
Emory University
Researchers at Georgia Tech (Atlanta, USA) and Emory University (Atlanta, GA, USA) are conducting a study to develop improved regenerative medicine strategies to aid repair of tendinopathic tissues. Since one of the hallmarks of tendinopathy is disruption of extracellular matrix (ECM), and particularly collagen, the researcher set out to test which classes of ECM proteases are involved in the tissue degeneration, and develop treatments to deliver inhibitory agents for these enzymes to reduce pathology progression and improve healing.
The central hypothesis of the researchers is that long-term regulation of protease activity in tendinopathy using a protease inhibitor will result in greater tendon tissue structure and mechanical properties. To do so, proteases and inhibitors related to ECM degradation will be tested in vivo in a rat supraspinatus tendon overuse model. The researchers hope to develop a controlled, injectable carrier to achieve local, sustained release of protease inhibitors. The researchers will also study the histology and mechanics of the tendons after healing.
“Normally people focus on treating tendon injuries after the tear has occurred, but we’re focusing on a much earlier stage in the disease,” said lead researcher associate professor Johnna Temenoff, PhD, of the department of Biomedical Engineering. “This is the first time that an injectable therapy specifically designed to interact with tissue at an early disease state has been attempted for this particular tendon injury.”
“We’re studying enzymes that are known to chew up the collagen, and we’re looking at then delivering inhibitors to those enzymes in a local injection in the tendon to try to stop the degradation,” added Dr. Temenoff. “We’re studying the disease in the shoulder, but it’s the same disease that causes tennis elbow, Achilles injuries, and jumper’s knee. It’s the same process, just in different tendons in the body.”
Tendinopathy is a common disorder resulting from repetitive motion in the workplace or during athletic activity that can cause severe pain and long-term disability due to tendon damage in the rotator cuff, a collation of four tendons made of collagen.
Related Links:
Georgia Tech
Emory University
Latest Surgical Techniques News
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots
- Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices
- Custom 3D-Printed Orthopedic Implants Transform Joint Replacement Surgery
- Wearable Technology Monitors and Analyzes Surgeons' Posture during Long Surgical Procedures
- Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery
- Computational Models Predict Heart Valve Leakage in Children
- Breakthrough Device Enables Clear and Real-Time Visual Guidance for Effective Cardiovascular Interventions
- World’s First Microscopic Probe to Revolutionize Early Cancer Diagnosis
- World’s Smallest Implantable Brain Stimulator Demonstrated in Human Patient
- Robotically Assisted Lung Transplants Could Soon Become a Reality
- AI to Provide Heart Transplant Surgeons with New Decision-Making Data
- New Surgical Tool Empowers Precision and Confidence in Operating Room